Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$283.23 - $323.1 $198,261 - $226,170
700 New
700 $220,000
Q1 2022

May 13, 2022

SELL
$221.42 - $260.97 $254,633 - $300,115
-1,150 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$177.01 - $223.45 $12,921 - $16,311
-73 Reduced 5.97%
1,150 $253,000
Q3 2021

Nov 12, 2021

BUY
$181.39 - $202.99 $27,208 - $30,448
150 Added 13.98%
1,223 $222,000
Q2 2021

Aug 13, 2021

BUY
$187.49 - $221.1 $201,176 - $237,240
1,073 New
1,073 $216,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Gabelli & CO Investment Advisers, Inc. Portfolio

Follow Gabelli & CO Investment Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli & CO Investment Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gabelli & CO Investment Advisers, Inc. with notifications on news.